02656 健康１６０
160 HEALTH
160 HEALTH
| Listing Date | 2025/09/17 |
| Listing Price | 11.890 |
Quote
Subscription Result
- Subscription Rate751.77x
- Guarantee One Lot Size--
- One Lot Success Rate8%
|
|
|
|
|
|
|
|
|
|
IPO Detail
COMPANY PROFILE
160 Health International is a pharmaceutical and healthcare product wholesaler and a leading digital healthcare integrated service provider in China. The Group provides customers with a wide selection of pharmaceutical and healthcare products, as well as comprehensive digital healthcare and wellness solutions. The Group provides pharmaceutical and healthcare products to business customers, including regional pharmaceutical trading companies, medical and healthcare institutions, and other pharmaceutical sales platforms, under wholesale model and individual users under retail model.
--
In providing digital healthcare and wellness solutions, the Group have developed Healthcare 160 Platform, a service platform that integrates healthcare and wellness services through online and offline channels, effectively connecting medical and healthcare institutions, medical professionals, and individual users. The Group’s platform provides a diverse array of healthcare and wellness services, encompassing both essential medical care and consumer healthcare services.
--
According to the report, the Group was the largest digital healthcare and wellness service platform in the digital healthcare integrated service industry in China in 2024, in terms of the number of appointments made through the platform in 2024, the number of cooperated hospitals as of December 31, 2024, the number of cooperated Class III hospitals as of December 31, 2024, and the number of medical professionals connected to the platform as of December 31, 2024. It had extended its service outreach to over 260 cities across China as of March 31, 2025.
--
As of March 31, 2025, the Group’s platform had connected with over 44,600 medical and healthcare institutions cumulatively since its inception, which comprised over 14,400 hospitals (including 3,430 Class III hospitals) and over 30,200 primary healthcare institutions, among its collaborating medical and healthcare institutions, there were over 6,800 private institutions primarily providing consumer healthcare services on its platform, such as dental, ophthalmology, and physical examination services.
BASIC INFORMATION
| Market | Hong Kong (Main Board) |
| Business Nature | Health Care |
| Major Business Area | China |
| Board Lot | 250 |
GLOBAL OFFERING
| No. of Offer Shares | 33.65M shares |
| No. of International Offer Shares | 30.28M shares |
| No. of HK Offer Shares | 3.36M shares |
| Offer Price | $11.89 - $14.86 |
| Stock Code | 2656 |
| Sponsor(s) | Shenwan Hongyuan Capital (H.K.) Limited, Zero2IPO Capital Limited |
| Underwriter(s) | Shenwan Hongyuan Securities (H.K.) Limited, Zero2IPO Securities Limited, ABCI Securities Company Limited, BOCI Asia Limited, Eddid Securities and Futures Limited, Innovation Securities Co., Limited, Sun Securities Limited, South China Securities Limited, Zhongtai International Securities Limited, Livermore Holdings Limited, uSmart Securities Limited, Valuable Capital Limited |
TIME TABLE
| Application Period | Sep 09 (Tue) - noon, Sep 12 (Fri) |
| Price Determination Date | Sep 15 (Mon) |
| Result Announcement Date | On or before Sep 16 (Tue) |
| Result Announcement Date | On or before Sep 16 (Tue) |
| Result Announcement Date | On or before Sep 17 (Wed) |
| Dealings in Shares commence on | Sep 17, 2025. (Wed) |
Reallocation of Shares Offered
Sales Statistics (HKD)
| Offer Price | $11.89 - $14.86 |
| Capitalization | 4.00B - 5.00B |
| NAV / share ($) | $0.76 - $1.04 (Unaudited pro forma adj NAV / share) |
Use Of Proceeds
| Assuming the offer price being at HKD 13.37, the net proceeds raised would be HKD 363.60M, of which |
| 40% : Broaden medical resources coverage and boost traffic to platform |
| 30% : Strengthen research and development capabilities, upgrading our IT infrastructure, and establishing 160 Internet Healthcare Research Institute |
| 10% : Diversify product and service offerings |
| 10% : Ｓtrategic cooperation and acquisition |
| 10% : Ｗorking capital |
Related Document
| Prospectus |  Chinese Version | English Version |
| Remark： | The above information is referenced from the prospectus. |
| All data is calculated from the non- exercise rights(if applicable). |
Name︰
--
--
--
Subscription --
Result Announcement --
Listing --Offer Price︰--
| Currency | : |
| Listing Price | : |
| Board Lot | : |
| Admission Fee* |
: |
| Subscribing Lot | : |
| Subscribing Fee | : |
| Subscribing Amount | : |
*Admission fees include brokerage of 1%, SFC transaction levy of 0.0027%, Stock Exchange trading fee of 0.005% and FRC transaction levy of 0.00015% (i.e. 1.0077% in total).